Connection

DOUGLAS D BOYD to Receptors, Cell Surface

This is a "connection" page, showing publications DOUGLAS D BOYD has written about Receptors, Cell Surface.
Connection Strength

2.765
  1. Identification of an histone H3 acetylated/K4-methylated-bound intragenic enhancer regulatory for urokinase receptor expression. Oncogene. 2007 Mar 29; 26(14):2058-70.
    View in: PubMed
    Score: 0.218
  2. Plasticity in urokinase-type plasminogen activator receptor (uPAR) display in colon cancer yields metastable subpopulations oscillating in cell surface uPAR density--implications in tumor progression. Cancer Res. 2006 Aug 15; 66(16):7957-67.
    View in: PubMed
    Score: 0.216
  3. A bisanthracycline (WP631) represses uPAR gene expression and cell migration of RKO colon cancer cells by interfering with transcription factor binding to a chromatin-accessible -148/-124 promoter region. Oncol Res. 2005; 15(5):265-79.
    View in: PubMed
    Score: 0.193
  4. The Kruppel-like KLF4 transcription factor, a novel regulator of urokinase receptor expression, drives synthesis of this binding site in colonic crypt luminal surface epithelial cells. J Biol Chem. 2004 May 21; 279(21):22674-83.
    View in: PubMed
    Score: 0.183
  5. Combination of an SRC kinase inhibitor with a novel pharmacological antagonist of the urokinase receptor diminishes in vitro colon cancer invasiveness. Clin Cancer Res. 2004 Feb 15; 10(4):1545-55.
    View in: PubMed
    Score: 0.182
  6. Transgenic mice demonstrate novel promoter regions for tissue-specific expression of the urokinase receptor gene. Am J Pathol. 2003 Aug; 163(2):453-64.
    View in: PubMed
    Score: 0.175
  7. A urokinase-derived peptide (A6) increases survival of mice bearing orthotopically grown prostate cancer and reduces lymph node metastasis. Am J Pathol. 2003 Feb; 162(2):619-26.
    View in: PubMed
    Score: 0.169
  8. Identification of a novel nuclear factor-kappaB sequence involved in expression of urokinase-type plasminogen activator receptor. Eur J Biochem. 2000 Jun; 267(11):3248-54.
    View in: PubMed
    Score: 0.141
  9. Transcriptional induction of the urokinase receptor gene by a constitutively active Src. Requirement of an upstream motif (-152/-135) bound with Sp1. J Biol Chem. 1999 Jun 25; 274(26):18428-37.
    View in: PubMed
    Score: 0.132
  10. Transactivation of the urokinase-type plasminogen activator receptor gene through a novel promoter motif bound with an activator protein-2alpha-related factor. J Biol Chem. 1999 Feb 19; 274(8):4702-14.
    View in: PubMed
    Score: 0.129
  11. Stimulation of urokinase-type plasminogen activator receptor expression by PMA requires JNK1-dependent and -independent signaling modules. Oncogene. 1998 Jul 16; 17(2):213-25.
    View in: PubMed
    Score: 0.123
  12. Requirement of an upstream AP-1 motif for the constitutive and phorbol ester-inducible expression of the urokinase-type plasminogen activator receptor gene. J Biol Chem. 1996 Sep 20; 271(38):23176-84.
    View in: PubMed
    Score: 0.109
  13. Transcriptional activation of the urokinase receptor gene in invasive colon cancer. Int J Cancer. 1994 Sep 01; 58(5):650-7.
    View in: PubMed
    Score: 0.094
  14. Expression of urokinase and its receptor in invasive and non-invasive prostate cancer cell lines. Thromb Haemost. 1992 Dec 07; 68(6):662-6.
    View in: PubMed
    Score: 0.084
  15. Decreased urokinase receptor expression by overexpression of the plasminogen activator in a colon cancer cell line. Biochem J. 1992 Jul 15; 285 ( Pt 2):629-34.
    View in: PubMed
    Score: 0.081
  16. Regulation of the urokinase receptor by its plasminogen activator. Thromb Haemost. 1991 Dec 02; 66(6):678-83.
    View in: PubMed
    Score: 0.078
  17. Role of the urokinase receptor in facilitating extracellular matrix invasion by cultured colon cancer. Cancer Res. 1991 Jul 15; 51(14):3690-5.
    View in: PubMed
    Score: 0.076
  18. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice. Cancer Res. 2005 Sep 01; 65(17):7775-81.
    View in: PubMed
    Score: 0.051
  19. Decoy molecules based on PNA-DNA chimeras and targeting Sp1 transcription factors inhibit the activity of urokinase-type plasminogen activator receptor (uPAR) promoter. Oncol Res. 2005; 15(7-8):373-83.
    View in: PubMed
    Score: 0.048
  20. Tumor-specific transcription factor binding to an activator protein-2/Sp1 element of the urokinase-type plasminogen activator receptor promoter in a first large series of resected gastrointestinal cancers. Clin Cancer Res. 2003 Jun; 9(6):2267-76.
    View in: PubMed
    Score: 0.043
  21. Regulation of the urokinase-type plasminogen activator receptor gene in different grades of human glioma cell lines. Clin Cancer Res. 2001 Feb; 7(2):267-76.
    View in: PubMed
    Score: 0.037
  22. Heregulin regulation of urokinase plasminogen activator and its receptor: human breast epithelial cell invasion. Cancer Res. 2001 Jan 01; 61(1):400-5.
    View in: PubMed
    Score: 0.037
  23. A region between -141 and -61 bp containing a proximal AP-1 is essential for constitutive expression of urokinase-type plasminogen activator receptor. Eur J Biochem. 1999 Aug; 264(1):92-9.
    View in: PubMed
    Score: 0.033
  24. In vitro inhibition of human glioblastoma cell line invasiveness by antisense uPA receptor. Oncogene. 1997 Mar 20; 14(11):1351-9.
    View in: PubMed
    Score: 0.028
  25. Modulation of in vitro invasion of human glioblastoma cells by urokinase-type plasminogen activator receptor antibody. Cancer Res. 1993 Sep 15; 53(18):4143-7.
    View in: PubMed
    Score: 0.022
  26. Overexpression of urokinase receptor increases matrix invasion without altering cell migration in a human osteosarcoma cell line. Cancer Res. 1993 Jul 01; 53(13):3109-17.
    View in: PubMed
    Score: 0.022
  27. Regulation of urokinase-type plasminogen activator expression in squamous-cell carcinoma of the oral cavity. Int J Cancer. 1993 Apr 22; 54(1):73-80.
    View in: PubMed
    Score: 0.021
  28. Involvement of urokinase and its receptor in the invasiveness of human prostatic carcinoma cell lines. Cancer Commun. 1991 Aug; 3(8):255-64.
    View in: PubMed
    Score: 0.019
  29. Inducible changes in cell size and attachment area due to expression of a mutant SWI/SNF chromatin remodeling enzyme. J Cell Sci. 2004 Nov 15; 117(Pt 24):5847-54.
    View in: PubMed
    Score: 0.012
  30. Activation of Src kinase in primary colorectal carcinoma: an indicator of poor clinical prognosis. Cancer. 2002 Jan 15; 94(2):344-51.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.